Spring direct naar de hoofdnavigatie of de inhoud

SME

Midsized companies are a driving force for innovation. In fact, some of the greatest inventions were made by midcorporates. However, often the expertise to protect these inventions is not available in-house. This is where we come in. With our hands-on knowledge and experience, you are able to obtain protection for your inventions and make them a valuable asset for your company.

Great number of midcorporate clients

Amongst our clients are a great number of midcorporates. We handle any of the IP issues that you may encounter. For example, we draft your patent applications, defend your patents or assert your patents against 3rd parties that may be using your inventions. We help you to build up a balanced portfolio and manage it successfully, so that the value of your Intellectual Property is maximized.

All relevant expertise for your business

With more than 60 attorneys we cover a broad field of specialisms and sectors. This ensures that you will work with an attorney that has knowledge and experience that is relevant to your business. Our offices are located in regions that are centres of innovation throughout the Netherlands, Belgium and Germany, so we’re always close to you. With a well developed network of patent agencies worldwide, we can ensure the best form of protection worldwide.

Dedicated team

A dedicated team of patent attorneys is at your disposal to provide the services that are needed by companies like yours. With this team, we always strive to find new ways to maximize the value of your innovations and achieve a balance between costs and potential revenues.

Contact our experts

Marco Molling

Marco Molling

  • European, Dutch and Belgian Patent Attorney, European Patent Litigator
  • Partner
More experts

News

UPC anti-anti-suit injunctions as interim measures: Munich Local Division in Huawei v Netgear (UPC_CFI_791/2024)

In its Order of 11 December 2024 in UPC_CFI_791/2024 (Munich Local Division), the Unified Patent Court (UPC) granted an ex parte anti-anti-suit/anti-enforcement injunction (AASI/AAEI) to prevent steps in US proceedings that were said to obstruct UPC patent enforcement. The decision is noteworthy for its articulation of the UPC’s jurisdictional basis and the procedural framework for […]Continue reading

R 0016/23: the Enlarged Board confirms the mandatory nature of oral proceedings upon request under Article 116(1) EPC 

In R 0016/23 (Enlarged Board of Appeal, 21 November 2025), the Enlarged Board set aside a Legal Board of Appeal decision which had dismissed an appeal without holding requested oral proceedings. The decision is a clear statement that efficiency and “timely legal certainty” cannot, in themselves, justify restricting the scope of Article 116(1) EPC when […]Continue reading

Medical-device infringement and “standard use”: LD Munich on lege artis use and conditional revocation counterclaims (UPC_CFI_628/2024) 

In its decision on the merits in UPC_CFI_628/2024 (with the related revocation counterclaim UPC_CFI_125/2025), the Munich Local Division of the Unified Patent Court (UPC) addressed two practically relevant issues:Continue reading